Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Prevention of travellers' diarrhoea by Lactobacillus GG.

Oksanen PJ, Salminen S, Saxelin M, Hämäläinen P, Ihantola-Vormisto A, Muurasniemi-Isoviita L, Nikkari S, Oksanen T, Pörsti I, Salminen E, et al.

Ann Med. 1990 Feb;22(1):53-6.

PMID:
2184847
2.

A study of fructo oligosaccharides in the prevention of travellers' diarrhoea.

Cummings JH, Christie S, Cole TJ.

Aliment Pharmacol Ther. 2001 Aug;15(8):1139-45.

3.

Effectiveness of rifaximin in prevention of diarrhoea in individuals travelling to south and southeast Asia: a randomised, double-blind, placebo-controlled, phase 3 trial.

Zanger P, Nurjadi D, Gabor J, Gaile M, Kremsner PG.

Lancet Infect Dis. 2013 Nov;13(11):946-54. doi: 10.1016/S1473-3099(13)70221-4. Epub 2013 Sep 4.

PMID:
24012319
4.

Previous exposure in a high-risk area for travellers' diarrhoea within the past year is associated with a significant protective effect for travellers' diarrhoea: a prospective observational cohort study in travellers to South Asia.

Kuenzli E, Juergensen D, Kling K, Jaeger VK, DeCrom S, Steffen R, Widmer AF, Battegay M, Hatz C, Neumayr A.

J Travel Med. 2017 Sep 1;24(5). doi: 10.1093/jtm/tax056.

PMID:
28931148
5.

A meta-analysis of the use of rifaximin to prevent travellers' diarrhoea.

Ng QX, Ho CYX, Shin D, Venkatanarayanan N, Chan HW.

J Travel Med. 2017 Sep 1;24(5). doi: 10.1093/jtm/tax025. Review.

PMID:
28498921
6.

Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala.

Behrens RH, Cramer JP, Jelinek T, Shaw H, von Sonnenburg F, Wilbraham D, Weinke T, Bell DJ, Asturias E, Pauwells HL, Maxwell R, Paredes-Paredes M, Glenn GM, Dewasthaly S, Stablein DM, Jiang ZD, DuPont HL.

Lancet Infect Dis. 2014 Mar;14(3):197-204. doi: 10.1016/S1473-3099(13)70297-4. Epub 2013 Nov 29.

PMID:
24291168
7.

Travellers' diarrhoea and the effect of pre-travel health advice in general practice.

McIntosh IB, Reed JM, Power KG.

Br J Gen Pract. 1997 Feb;47(415):71-5.

8.

Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea.

Siitonen S, Vapaatalo H, Salminen S, Gordin A, Saxelin M, Wikberg R, Kirkkola AL.

Ann Med. 1990 Feb;22(1):57-9.

PMID:
2184848
9.

Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial.

Frech SA, Dupont HL, Bourgeois AL, McKenzie R, Belkind-Gerson J, Figueroa JF, Okhuysen PC, Guerrero NH, Martinez-Sandoval FG, Meléndez-Romero JH, Jiang ZD, Asturias EJ, Halpern J, Torres OR, Hoffman AS, Villar CP, Kassem RN, Flyer DC, Andersen BH, Kazempour K, Breisch SA, Glenn GM.

Lancet. 2008 Jun 14;371(9629):2019-25. doi: 10.1016/S0140-6736(08)60839-9.

PMID:
18554712
10.

Sodium butyrate and short chain fatty acids in prevention of travellers' diarrhoea: a randomized prospective study.

Krokowicz L, Kaczmarek BF, Krokowicz P, Stojcev Z, Mackiewicz J, Walkowiak J, Drews M, Banasiewicz T.

Travel Med Infect Dis. 2014 Mar-Apr;12(2):183-8. doi: 10.1016/j.tmaid.2013.08.008. Epub 2013 Sep 6.

PMID:
24063909
11.

Effectiveness in prevention of travellers' diarrhoea by an oral cholera vaccine WC/rBS.

López-Gigosos R, García-Fortea P, Reina-Doña E, Plaza-Martín E.

Travel Med Infect Dis. 2007 Nov;5(6):380-4. Epub 2007 Jul 30.

PMID:
17983977
12.
13.

Analysis of Escherichia coli isolates from subjects with travellers' diarrhoea using DNA probes and serotyping.

Rademaker CM, Krul MR, Jansen WH, Vos NM, Hoepelman IM, Rozenberg-Arska M, Verhoef J.

Eur J Clin Microbiol Infect Dis. 1991 Aug;10(8):625-9.

PMID:
1748115
14.

Systematic review: prevention of travellers' diarrhoea.

DuPont HL.

Aliment Pharmacol Ther. 2008 May;27(9):741-51. doi: 10.1111/j.1365-2036.2008.03647.x. Epub 2008 Feb 14. Review.

15.

Sentinel surveillance for travellers' diarrhoea in primary care.

Northey G, Evans MR, Sarvotham TS, Thomas DR, Howard TJ.

BMC Infect Dis. 2007 Nov 6;7:126.

16.

Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine.

Peltola H, Siitonen A, Kyrönseppä H, Simula I, Mattila L, Oksanen P, Kataja MJ, Cadoz M.

Lancet. 1991 Nov 23;338(8778):1285-9.

PMID:
1682684
19.

Reduction of travellers' diarrhoea by WC/rBS oral cholera vaccine in young, high-risk travellers.

Torrell JM, Aumatell CM, Ramos SM, Mestre LG, Salas CM.

Vaccine. 2009 Jun 19;27(30):4074-7. doi: 10.1016/j.vaccine.2009.04.025. Epub 2009 May 3.

PMID:
19376179
20.

Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea.

Ahmed T, Bhuiyan TR, Zaman K, Sinclair D, Qadri F.

Cochrane Database Syst Rev. 2013 Jul 5;(7):CD009029. doi: 10.1002/14651858.CD009029.pub2. Review.

Supplemental Content

Support Center